Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Public health targeting of PrEP at HIV positives’ bridging networks
2016-005078-37Phase 4Completed
- Sponsor
- Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases. Primary endpoint: Linkage to PrEP care. Started Mar 2017; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2016-005078-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005078-37.